YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed PhenotypeTaofeek K. Owonikoko, Gabriel Sica, Bhakti Dwivedi et al.|Journal of Thoracic Oncology|2020Cited by 166
Characteristics and anatomic location of PD-1 <sup>+</sup> TCF1 <sup>+</sup> stem-like CD8 T cells in chronic viral infection and cancerSe Jin Im, Rafi Ahmed, Tahseen H. Nasti et al.|Proceedings of the National Academy of Sciences|2023Cited by 80
Impact of TP53 mutations on efficacy of PD-1 targeted immunotherapy in non-small cell lung cancer (NSCLC).Jennifer W. Carlisle, Taofeek K. Owonikoko, Nhu Thi Nho et al.|Journal of Clinical Oncology|2018Cited by 13
YAP1 positive small-cell lung cancer subtype is associated with the T-cell inflamed gene expression profile and confers good prognosis and long term survival.Taofeek K. Owonikoko, Gabriel Sica, Bhakti Dwivedi et al.|Journal of Clinical Oncology|2020Cited by 8
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancerChangfa Shu, Haian Fu, Jianfeng Li et al.|Nature Communications|2025Cited by 7